Document ID: chunk:federal_register_of_legislation:F2022L00258:clause:1_1:p2
Version: federal_register_of_legislation:F2022L00258
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 2/5)
Character Range: 22909–26540

'cumulative equivalent dose' for the purpose of applying ionising radiation factors contained in Statements of Principles determined under Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian Radiation Protection and Nuclear Safety Agency, as in force on 2 August 2017.
         Note 1: Examples of circumstances that might lead to exposure to ionising radiation include being present during or subsequent to the testing or use of nuclear weapons, undergoing diagnostic or therapeutic medical procedures involving ionising radiation, and being a member of an aircrew, leading to increased levels of exposure to cosmic radiation.
         Note 2: For the purpose of dose reconstruction, dose is calculated as an average over the mass of a specific tissue or organ. If a tissue is exposed to multiple sources of ionising radiation, the various dose estimates for each type of radiation must be combined.
                                     equivalent glucocorticoid therapy means a glucocorticoid in the following table, at the doses specified in the table, or a therapeutically equivalent dose of another glucocorticoid:

 Glucocorticoid      Minimum cumulative  Minimum average
                     dose (milligram)    rate (milligram/day)
 betamethasone       45                  1.5
 cortisone           1,875               62.5
 dexamethasone       55                  1.8
 methylprednisolone  300                 10
 paramethasone       150                 5
 prednisolone        375                 12.5
 prednisone          375                 12.5
 triamcinolone       300                 10

                                     equivalent inhaled glucocorticoid means:
         (a)          2,000 micrograms of beclometasone;
         (b)          1,600 micrograms of ciclesonide;
         (c)          2,500 micrograms of fluticasone propionate;
         (d)          1,000 micrograms of fluticasone furoate;
         (e)          10,000 micrograms of triamcinolone; or
         (f)           a therapeutically equivalent dose of another inhaled glucocorticoid.
                             equivalent levels using ambulatory blood pressure measurement means:
         (a)          an average 24 hour blood pressure measurement of greater than or equal to 130 mmHg systolic or greater than or equal to 80 mmHg diastolic; or
         (b)          an average daytime (awake) blood pressure measurement of greater than or equal to 135 mmHg systolic or greater than or equal to 85 mmHg diastolic; or
         (c)          an average nighttime (asleep) blood pressure measurement of greater than or equal to 120 mmHg systolic or greater than or equal to 70 mmHg diastolic.
                                     glucocorticoid therapy as specified means:
         (a)          applying a high or very high potency topical glucocorticoid to at least 30% of total skin surface area, daily, for at least 6 months; or
         (b)          inhaling at least 4,000 micrograms of budesonide, or equivalent inhaled glucocorticoid, daily, for at least 6 months; or
         (c)          taking:
            (i)            hydrocortisone, orally or by injection:
                 1. to a cumulative dose of at least 1,500 milligrams; and
                 2. at a minimum dose rate averaging 50 milligrams per day; or
            (ii)         equivalent glucocorticoid therapy, orally or by injection; or
         (d)            using a glucocorticoid concurrently with a drug, daily, for at least 4 weeks, where that drug can inhibit the activity of the metabolising enzyme cytochrome P450 3A4 by at least 30% (moderate to